Association between Hasford Scoring System and Hematologic Response in Chronic and Accelerated Phase of Chronic Myelocytic Leukemia Patient with Imatinib for Three Months

• Main Authors: Andy Purnomo, Siprianus Ugroseno Yudho Bintoro, Made Putra Sedana, Ami Ashariati Prayoga
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Cell and BioPharmaceutical Institute 2019
• Subjects: R Medicine (General); RC Internal medicine
• Online Access: http://repository.unair.ac.id/96247/1/Association%20between%20hasford%20scoring%20system%20and%20hematologic%20response%20in%20chronic%20and%20accelerated%20phase%20of%20chronic%20myelocytic%20leukimia%20patient%20with%20Imatinib%20for%20three%20months.pdf; http://repository.unair.ac.id/96247/2/Association%20between%20Hasford%20Scoring.pdf; http://repository.unair.ac.id/96247/3/Association%20between%20hasford%20scoring%20system%20and%20hematologic%20response%20in%20chronic%20and%20accelerated%20phase%20of%20chronic%20myelocytic%20leukimia%20patient%20with%20Imatinib%20for%20three%20months.pdf; http://repository.unair.ac.id/96247/; https://www.cellbiopharm.com/ojs/index.php/MCBS/article/view/56; https://doi.org/10.21705/mcbs.v3i2.56
• Institution: Universitas Airlangga

Background: Hasford score is a scoring system which was made in interferon treatment era to assess chronic myelocytic leukemia (CML) prognosis. Complete hematologic response (CHR) is the milestone of prognosis evaluation. CHR achievement will significantly increase survival. Imatinib is a revolution...